Guildford, UK, 1 July 2013: ReNeuron will announce its preliminary results for the year ended 31 March 2013 on Thursday 25 July 2013.
A meeting for analysts will be held at 10am on the day of the results at the offices of Buchanan, 107 Cheapside, London, EC2V 6DN.
For a webcast of the analyst and investor presentation, please log on to the following web address about 10 minutes before 10am on the day of the results:
– Ends –
ReNeuron +44 (0) 1483 302560
Michael Hunt, Chief Executive Officer
Dr John Sinden, Chief Scientific Officer
Buchanan +44 (0) 20 7466 5000
Mark Court, Fiona Henson, Sophie Cowles
Cenkos Securities +44 (0) 20 7397 8900
Stephen Keys, Adrian Hargrave (NOMAD and Broker)
Andy Roberts (Sales)
ReNeuron’s shares are traded on the London AIM market under the symbol RENE.L. Further information on ReNeuron and its products can be found at www.reneuron.com.